| 25 | CNCOpen CNC on Seeking Alpha in a new tab.89% of the way from the 52-week low to the 52-week high. | CenteneHealthcare·Medical - Healthcare Plans | 97 | 87Quality: 87th percentile | 90Momentum: 90th percentile | 54Growth: 54th percentile | 83Valuation: 83rd percentile | 98Expectations: 98th percentile | QQuality87Quality: 87th percentileMMomentum90Momentum: 90th percentileGGrowth54Growth: 54th percentileVValuation83Valuation: 83rd percentileEExpectations98Expectations: 98th percentile |
| 29 | NTRAOpen NTRA on Seeking Alpha in a new tab.87% of the way from the 52-week low to the 52-week high. | NateraHealthcare·Medical - Diagnostics & Research | 96 | 95Quality: 95th percentile | 98Momentum: 98th percentile | 15Growth: 15th percentile | 3Valuation: 3rd percentile | 45Expectations: 45th percentile | QQuality95Quality: 95th percentileMMomentum98Momentum: 98th percentileGGrowth15Growth: 15th percentileVValuation3Valuation: 3rd percentileEExpectations45Expectations: 45th percentile |
| 35 | HUMOpen HUM on Seeking Alpha in a new tab.87% of the way from the 52-week low to the 52-week high. | HumanaHealthcare·Medical - Healthcare Plans | 95 | 93Quality: 93rd percentile | 96Momentum: 96th percentile | 9Growth: 9th percentile | 76Valuation: 76th percentile | 44Expectations: 44th percentile | QQuality93Quality: 93rd percentileMMomentum96Momentum: 96th percentileGGrowth9Growth: 9th percentileVValuation76Valuation: 76th percentileEExpectations44Expectations: 44th percentile |
| 38 | LLYOpen LLY on Seeking Alpha in a new tab.92% of the way from the 52-week low to the 52-week high. | Eli Lilly and CompanyHealthcare·Drug Manufacturers - General | 95 | 66Quality: 66th percentile | 89Momentum: 89th percentile | 93Growth: 93rd percentile | 7Valuation: 7th percentile | 90Expectations: 90th percentile | QQuality66Quality: 66th percentileMMomentum89Momentum: 89th percentileGGrowth93Growth: 93rd percentileVValuation7Valuation: 7th percentileEExpectations90Expectations: 90th percentile |
| 39 | DXCMOpen DXCM on Seeking Alpha in a new tab.64% of the way from the 52-week low to the 52-week high. | DexComHealthcare·Medical - Devices | 95 | 82Quality: 82nd percentile | 90Momentum: 90th percentile | 86Growth: 86th percentile | 39Valuation: 39th percentile | 76Expectations: 76th percentile | QQuality82Quality: 82nd percentileMMomentum90Momentum: 90th percentileGGrowth86Growth: 86th percentileVValuation39Valuation: 39th percentileEExpectations76Expectations: 76th percentile |
| 40 | TECHOpen TECH on Seeking Alpha in a new tab.100% of the way from the 52-week low to the 52-week high. | Bio-TechneHealthcare·Biotechnology | 94 | 86Quality: 86th percentile | 88Momentum: 88th percentile | 92Growth: 92nd percentile | 17Valuation: 17th percentile | 16Expectations: 16th percentile | QQuality86Quality: 86th percentileMMomentum88Momentum: 88th percentileGGrowth92Growth: 92nd percentileVValuation17Valuation: 17th percentileEExpectations16Expectations: 16th percentile |
| 41 | TEMOpen TEM on Seeking Alpha in a new tab.50% of the way from the 52-week low to the 52-week high. | Tempus AIHealthcare·Medical - Healthcare Information Services | 94 | 85Quality: 85th percentile | 93Momentum: 93rd percentile | 8Growth: 8th percentile | 4Valuation: 4th percentile | 96Expectations: 96th percentile | QQuality85Quality: 85th percentileMMomentum93Momentum: 93rd percentileGGrowth8Growth: 8th percentileVValuation4Valuation: 4th percentileEExpectations96Expectations: 96th percentile |
| 53 | GHOpen GH on Seeking Alpha in a new tab.86% of the way from the 52-week low to the 52-week high. | Guardant HealthHealthcare·Medical - Diagnostics & Research | 93 | –No data | 97Momentum: 97th percentile | 75Growth: 75th percentile | 2Valuation: 2nd percentile | 4Expectations: 4th percentile | QQuality–No dataMMomentum97Momentum: 97th percentileGGrowth75Growth: 75th percentileVValuation2Valuation: 2nd percentileEExpectations4Expectations: 4th percentile |
| 61 | THCOpen THC on Seeking Alpha in a new tab.89% of the way from the 52-week low to the 52-week high. | Tenet HealthcareHealthcare·Medical - Care Facilities | 91 | 67Quality: 67th percentile | 90Momentum: 90th percentile | 82Growth: 82nd percentile | 92Valuation: 92nd percentile | 94Expectations: 94th percentile | QQuality67Quality: 67th percentileMMomentum90Momentum: 90th percentileGGrowth82Growth: 82nd percentileVValuation92Valuation: 92nd percentileEExpectations94Expectations: 94th percentile |
| 64 | ALNYOpen ALNY on Seeking Alpha in a new tab.10% of the way from the 52-week low to the 52-week high. | Alnylam PharmaceuticalsHealthcare·Biotechnology | 91 | 96Quality: 96th percentile | 12Momentum: 12th percentile | 97Growth: 97th percentile | 21Valuation: 21st percentile | 3Expectations: 3rd percentile | QQuality96Quality: 96th percentileMMomentum12Momentum: 12th percentileGGrowth97Growth: 97th percentileVValuation21Valuation: 21st percentileEExpectations3Expectations: 3rd percentile |
| 67 | SOLVOpen SOLV on Seeking Alpha in a new tab.74% of the way from the 52-week low to the 52-week high. | SolventumHealthcare·Medical - Instruments & Supplies | 91 | 53Quality: 53rd percentile | 87Momentum: 87th percentile | 91Growth: 91st percentile | 65Valuation: 65th percentile | 91Expectations: 91st percentile | QQuality53Quality: 53rd percentileMMomentum87Momentum: 87th percentileGGrowth91Growth: 91st percentileVValuation65Valuation: 65th percentileEExpectations91Expectations: 91st percentile |
| 78 | HALOOpen HALO on Seeking Alpha in a new tab.100% of the way from the 52-week low to the 52-week high. | Halozyme TherapeuticsHealthcare·Biotechnology | 89 | 27Quality: 27th percentile | 96Momentum: 96th percentile | 49Growth: 49th percentile | 26Valuation: 26th percentile | 89Expectations: 89th percentile | QQuality27Quality: 27th percentileMMomentum96Momentum: 96th percentileGGrowth49Growth: 49th percentileVValuation26Valuation: 26th percentileEExpectations89Expectations: 89th percentile |
| 86 | INSMOpen INSM on Seeking Alpha in a new tab.2% of the way from the 52-week low to the 52-week high. | InsmedHealthcare·Biotechnology | 88 | 20Quality: 20th percentile | 18Momentum: 18th percentile | 98Growth: 98th percentile | 1Valuation: 1st percentile | 97Expectations: 97th percentile | QQuality20Quality: 20th percentileMMomentum18Momentum: 18th percentileGGrowth98Growth: 98th percentileVValuation1Valuation: 1st percentileEExpectations97Expectations: 97th percentile |
| 87 | EXELOpen EXEL on Seeking Alpha in a new tab.98% of the way from the 52-week low to the 52-week high. | ExelixisHealthcare·Biotechnology | 88 | 96Quality: 96th percentile | 88Momentum: 88th percentile | 25Growth: 25th percentile | 56Valuation: 56th percentile | 55Expectations: 55th percentile | QQuality96Quality: 96th percentileMMomentum88Momentum: 88th percentileGGrowth25Growth: 25th percentileVValuation56Valuation: 56th percentileEExpectations55Expectations: 55th percentile |
| 91 | NBIXOpen NBIX on Seeking Alpha in a new tab.37% of the way from the 52-week low to the 52-week high. | Neurocrine BiosciencesHealthcare·Biotechnology | 87 | 72Quality: 72nd percentile | 66Momentum: 66th percentile | 86Growth: 86th percentile | 64Valuation: 64th percentile | 95Expectations: 95th percentile | QQuality72Quality: 72nd percentileMMomentum66Momentum: 66th percentileGGrowth86Growth: 86th percentileVValuation64Valuation: 64th percentileEExpectations95Expectations: 95th percentile |
| 107 | VTRSOpen VTRS on Seeking Alpha in a new tab.95% of the way from the 52-week low to the 52-week high. | ViatrisHealthcare·Drug Manufacturers - Specialty & Generic | 85 | 67Quality: 67th percentile | 83Momentum: 83rd percentile | 83Growth: 83rd percentile | 79Valuation: 79th percentile | 76Expectations: 76th percentile | QQuality67Quality: 67th percentileMMomentum83Momentum: 83rd percentileGGrowth83Growth: 83rd percentileVValuation79Valuation: 79th percentileEExpectations76Expectations: 76th percentile |
| 112 | RVTYOpen RVTY on Seeking Alpha in a new tab.93% of the way from the 52-week low to the 52-week high. | RevvityHealthcare·Medical - Diagnostics & Research | 84 | 29Quality: 29th percentile | 95Momentum: 95th percentile | 14Growth: 14th percentile | 39Valuation: 39th percentile | 79Expectations: 79th percentile | QQuality29Quality: 29th percentileMMomentum95Momentum: 95th percentileGGrowth14Growth: 14th percentileVValuation39Valuation: 39th percentileEExpectations79Expectations: 79th percentile |
| 120 | CRLOpen CRL on Seeking Alpha in a new tab.100% of the way from the 52-week low to the 52-week high. | Charles River Laboratories InternationalHealthcare·Medical - Diagnostics & Research | 83 | 32Quality: 32nd percentile | 95Momentum: 95th percentile | 15Growth: 15th percentile | 22Valuation: 22nd percentile | 67Expectations: 67th percentile | QQuality32Quality: 32nd percentileMMomentum95Momentum: 95th percentileGGrowth15Growth: 15th percentileVValuation22Valuation: 22nd percentileEExpectations67Expectations: 67th percentile |
| 121 | AOpen A on Seeking Alpha in a new tab.96% of the way from the 52-week low to the 52-week high. | Agilent TechnologiesHealthcare·Medical - Diagnostics & Research | 83 | 47Quality: 47th percentile | 92Momentum: 92nd percentile | 55Growth: 55th percentile | 24Valuation: 24th percentile | 62Expectations: 62nd percentile | QQuality47Quality: 47th percentileMMomentum92Momentum: 92nd percentileGGrowth55Growth: 55th percentileVValuation24Valuation: 24th percentileEExpectations62Expectations: 62nd percentile |
| 124 | MEDPOpen MEDP on Seeking Alpha in a new tab.98% of the way from the 52-week low to the 52-week high. | MedpaceHealthcare·Medical - Diagnostics & Research | 82 | 55Quality: 55th percentile | 91Momentum: 91st percentile | 48Growth: 48th percentile | 20Valuation: 20th percentile | 63Expectations: 63rd percentile | QQuality55Quality: 55th percentileMMomentum91Momentum: 91st percentileGGrowth48Growth: 48th percentileVValuation20Valuation: 20th percentileEExpectations63Expectations: 63rd percentile |
| 127 | ABBVOpen ABBV on Seeking Alpha in a new tab.95% of the way from the 52-week low to the 52-week high. | AbbVieHealthcare·Drug Manufacturers - General | 82 | –No data | 89Momentum: 89th percentile | 77Growth: 77th percentile | 29Valuation: 29th percentile | 22Expectations: 22nd percentile | QQuality–No dataMMomentum89Momentum: 89th percentileGGrowth77Growth: 77th percentileVValuation29Valuation: 29th percentileEExpectations22Expectations: 22nd percentile |
| 128 | ELVOpen ELV on Seeking Alpha in a new tab.89% of the way from the 52-week low to the 52-week high. | Elevance HealthHealthcare·Medical - Healthcare Plans | 82 | 93Quality: 93rd percentile | 72Momentum: 72nd percentile | 9Growth: 9th percentile | 95Valuation: 95th percentile | 94Expectations: 94th percentile | QQuality93Quality: 93rd percentileMMomentum72Momentum: 72nd percentileGGrowth9Growth: 9th percentileVValuation95Valuation: 95th percentileEExpectations94Expectations: 94th percentile |
| 136 | WSTOpen WST on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high. | West Pharmaceutical ServicesHealthcare·Medical - Instruments & Supplies | 81 | 78Quality: 78th percentile | 83Momentum: 83rd percentile | 55Growth: 55th percentile | 12Valuation: 12th percentile | 75Expectations: 75th percentile | QQuality78Quality: 78th percentileMMomentum83Momentum: 83rd percentileGGrowth55Growth: 55th percentileVValuation12Valuation: 12th percentileEExpectations75Expectations: 75th percentile |
| 137 | COROpen COR on Seeking Alpha in a new tab.66% of the way from the 52-week low to the 52-week high. | CencoraHealthcare·Medical - Distribution | 80 | 89Quality: 89th percentile | 45Momentum: 45th percentile | 79Growth: 79th percentile | 64Valuation: 64th percentile | 33Expectations: 33rd percentile | QQuality89Quality: 89th percentileMMomentum45Momentum: 45th percentileGGrowth79Growth: 79th percentileVValuation64Valuation: 64th percentileEExpectations33Expectations: 33rd percentile |
| 140 | IQVOpen IQV on Seeking Alpha in a new tab.93% of the way from the 52-week low to the 52-week high. | IQVIAHealthcare·Medical - Diagnostics & Research | 80 | 24Quality: 24th percentile | 94Momentum: 94th percentile | 34Growth: 34th percentile | 49Valuation: 49th percentile | 39Expectations: 39th percentile | QQuality24Quality: 24th percentileMMomentum94Momentum: 94th percentileGGrowth34Growth: 34th percentileVValuation49Valuation: 49th percentileEExpectations39Expectations: 39th percentile |
| 142 | ELANOpen ELAN on Seeking Alpha in a new tab.41% of the way from the 52-week low to the 52-week high. | Elanco Animal HealthHealthcare·Drug Manufacturers - Specialty & Generic | 80 | 61Quality: 61st percentile | 48Momentum: 48th percentile | 89Growth: 89th percentile | 59Valuation: 59th percentile | 89Expectations: 89th percentile | QQuality61Quality: 61st percentileMMomentum48Momentum: 48th percentileGGrowth89Growth: 89th percentileVValuation59Valuation: 59th percentileEExpectations89Expectations: 89th percentile |
| 148 | BBIOOpen BBIO on Seeking Alpha in a new tab.36% of the way from the 52-week low to the 52-week high. | BridgeBio PharmaHealthcare·Biotechnology | 79 | –No data | 19Momentum: 19th percentile | 99Growth: 99th percentile | 0Valuation: 0th percentile | 2Expectations: 2nd percentile | QQuality–No dataMMomentum19Momentum: 19th percentileGGrowth99Growth: 99th percentileVValuation0Valuation: 0th percentileEExpectations2Expectations: 2nd percentile |
| 149 | AVTROpen AVTR on Seeking Alpha in a new tab.98% of the way from the 52-week low to the 52-week high. | AvantorHealthcare·Medical - Instruments & Supplies | 79 | 20Quality: 20th percentile | 97Momentum: 97th percentile | 6Growth: 6th percentile | 52Valuation: 52nd percentile | 65Expectations: 65th percentile | QQuality20Quality: 20th percentileMMomentum97Momentum: 97th percentileGGrowth6Growth: 6th percentileVValuation52Valuation: 52nd percentileEExpectations65Expectations: 65th percentile |
| 158 | BTSGOpen BTSG on Seeking Alpha in a new tab.66% of the way from the 52-week low to the 52-week high. | BrightSpring Health ServicesHealthcare·Medical - Healthcare Information Services | 77 | 99Quality: 99th percentile | 77Momentum: 77th percentile | 0Growth: 0th percentile | 50Valuation: 50th percentile | 74Expectations: 74th percentile | QQuality99Quality: 99th percentileMMomentum77Momentum: 77th percentileGGrowth0Growth: 0th percentileVValuation50Valuation: 50th percentileEExpectations74Expectations: 74th percentile |
| 165 | ILMNOpen ILMN on Seeking Alpha in a new tab.82% of the way from the 52-week low to the 52-week high. | IlluminaHealthcare·Medical - Diagnostics & Research | 76 | 26Quality: 26th percentile | 98Momentum: 98th percentile | 3Growth: 3rd percentile | 10Valuation: 10th percentile | 54Expectations: 54th percentile | QQuality26Quality: 26th percentileMMomentum98Momentum: 98th percentileGGrowth3Growth: 3rd percentileVValuation10Valuation: 10th percentileEExpectations54Expectations: 54th percentile |
| 168 | TMOOpen TMO on Seeking Alpha in a new tab.92% of the way from the 52-week low to the 52-week high. | Thermo Fisher ScientificHealthcare·Medical - Diagnostics & Research | 76 | 36Quality: 36th percentile | 91Momentum: 91st percentile | 57Growth: 57th percentile | 36Valuation: 36th percentile | 42Expectations: 42nd percentile | QQuality36Quality: 36th percentileMMomentum91Momentum: 91st percentileGGrowth57Growth: 57th percentileVValuation36Valuation: 36th percentileEExpectations42Expectations: 42nd percentile |
| 174 | CVSOpen CVS on Seeking Alpha in a new tab.60% of the way from the 52-week low to the 52-week high. | CVS HealthHealthcare·Medical - Healthcare Plans | 75 | 71Quality: 71st percentile | 74Momentum: 74th percentile | 43Growth: 43rd percentile | 95Valuation: 95th percentile | 92Expectations: 92nd percentile | QQuality71Quality: 71st percentileMMomentum74Momentum: 74th percentileGGrowth43Growth: 43rd percentileVValuation95Valuation: 95th percentileEExpectations92Expectations: 92nd percentile |
| 190 | AMGNOpen AMGN on Seeking Alpha in a new tab.96% of the way from the 52-week low to the 52-week high. | AmgenHealthcare·Drug Manufacturers - General | 73 | 60Quality: 60th percentile | 84Momentum: 84th percentile | 60Growth: 60th percentile | 35Valuation: 35th percentile | 71Expectations: 71st percentile | QQuality60Quality: 60th percentileMMomentum84Momentum: 84th percentileGGrowth60Growth: 60th percentileVValuation35Valuation: 35th percentileEExpectations71Expectations: 71st percentile |
| 194 | INCYOpen INCY on Seeking Alpha in a new tab.60% of the way from the 52-week low to the 52-week high. | IncyteHealthcare·Biotechnology | 72 | 62Quality: 62nd percentile | 87Momentum: 87th percentile | 8Growth: 8th percentile | 82Valuation: 82nd percentile | 94Expectations: 94th percentile | QQuality62Quality: 62nd percentileMMomentum87Momentum: 87th percentileGGrowth8Growth: 8th percentileVValuation82Valuation: 82nd percentileEExpectations94Expectations: 94th percentile |
| 200 | MOHOpen MOH on Seeking Alpha in a new tab.68% of the way from the 52-week low to the 52-week high. | Molina HealthcareHealthcare·Medical - Healthcare Plans | 71 | 89Quality: 89th percentile | 62Momentum: 62nd percentile | 15Growth: 15th percentile | 51Valuation: 51st percentile | 73Expectations: 73rd percentile | QQuality89Quality: 89th percentileMMomentum62Momentum: 62nd percentileGGrowth15Growth: 15th percentileVValuation51Valuation: 51st percentileEExpectations73Expectations: 73rd percentile |
| 202 | BAXOpen BAX on Seeking Alpha in a new tab.67% of the way from the 52-week low to the 52-week high. | Baxter InternationalHealthcare·Medical - Instruments & Supplies | 71 | 34Quality: 34th percentile | 86Momentum: 86th percentile | 28Growth: 28th percentile | 65Valuation: 65th percentile | 95Expectations: 95th percentile | QQuality34Quality: 34th percentileMMomentum86Momentum: 86th percentileGGrowth28Growth: 28th percentileVValuation65Valuation: 65th percentileEExpectations95Expectations: 95th percentile |
| 222 | RVMDOpen RVMD on Seeking Alpha in a new tab.76% of the way from the 52-week low to the 52-week high. | Revolution MedicinesHealthcare·Biotechnology | 68 | –No data | 93Momentum: 93rd percentile | 14Growth: 14th percentile | 3Valuation: 3rd percentile | 2Expectations: 2nd percentile | QQuality–No dataMMomentum93Momentum: 93rd percentileGGrowth14Growth: 14th percentileVValuation3Valuation: 3rd percentileEExpectations2Expectations: 2nd percentile |
| 225 | CIOpen CI on Seeking Alpha in a new tab.87% of the way from the 52-week low to the 52-week high. | CignaHealthcare·Medical - Healthcare Plans | 68 | 78Quality: 78th percentile | 40Momentum: 40th percentile | 72Growth: 72nd percentile | 98Valuation: 98th percentile | 28Expectations: 28th percentile | QQuality78Quality: 78th percentileMMomentum40Momentum: 40th percentileGGrowth72Growth: 72nd percentileVValuation98Valuation: 98th percentileEExpectations28Expectations: 28th percentile |
| 245 | MDGLOpen MDGL on Seeking Alpha in a new tab.20% of the way from the 52-week low to the 52-week high. | Madrigal PharmaceuticalsHealthcare·Biotechnology | 65 | 75Quality: 75th percentile | 45Momentum: 45th percentile | 39Growth: 39th percentile | 5Valuation: 5th percentile | 88Expectations: 88th percentile | QQuality75Quality: 75th percentileMMomentum45Momentum: 45th percentileGGrowth39Growth: 39th percentileVValuation5Valuation: 5th percentileEExpectations88Expectations: 88th percentile |
| 251 | IDXXOpen IDXX on Seeking Alpha in a new tab.26% of the way from the 52-week low to the 52-week high. | IDEXX LaboratoriesHealthcare·Medical - Diagnostics & Research | 64 | 84Quality: 84th percentile | 23Momentum: 23rd percentile | 59Growth: 59th percentile | 12Valuation: 12th percentile | 61Expectations: 61st percentile | QQuality84Quality: 84th percentileMMomentum23Momentum: 23rd percentileGGrowth59Growth: 59th percentileVValuation12Valuation: 12th percentileEExpectations61Expectations: 61st percentile |
| 252 | LHOpen LH on Seeking Alpha in a new tab.89% of the way from the 52-week low to the 52-week high. | LabcorpHealthcare·Medical - Diagnostics & Research | 64 | 65Quality: 65th percentile | 78Momentum: 78th percentile | 23Growth: 23rd percentile | 66Valuation: 66th percentile | 42Expectations: 42nd percentile | QQuality65Quality: 65th percentileMMomentum78Momentum: 78th percentileGGrowth23Growth: 23rd percentileVValuation66Valuation: 66th percentileEExpectations42Expectations: 42nd percentile |
| 266 | DVAOpen DVA on Seeking Alpha in a new tab.57% of the way from the 52-week low to the 52-week high. | DaVitaHealthcare·Medical - Care Facilities | 62 | –No data | 79Momentum: 79th percentile | 40Growth: 40th percentile | 97Valuation: 97th percentile | 37Expectations: 37th percentile | QQuality–No dataMMomentum79Momentum: 79th percentileGGrowth40Growth: 40th percentileVValuation97Valuation: 97th percentileEExpectations37Expectations: 37th percentile |
| 269 | WATOpen WAT on Seeking Alpha in a new tab.95% of the way from the 52-week low to the 52-week high. | WatersHealthcare·Medical - Diagnostics & Research | 61 | 7Quality: 7th percentile | 91Momentum: 91st percentile | 50Growth: 50th percentile | 19Valuation: 19th percentile | 23Expectations: 23rd percentile | QQuality7Quality: 7th percentileMMomentum91Momentum: 91st percentileGGrowth50Growth: 50th percentileVValuation19Valuation: 19th percentileEExpectations23Expectations: 23rd percentile |
| 273 | MTDOpen MTD on Seeking Alpha in a new tab.94% of the way from the 52-week low to the 52-week high. | Mettler-Toledo InternationalHealthcare·Medical - Diagnostics & Research | 61 | –No data | 79Momentum: 79th percentile | 36Growth: 36th percentile | 13Valuation: 13th percentile | 49Expectations: 49th percentile | QQuality–No dataMMomentum79Momentum: 79th percentileGGrowth36Growth: 36th percentileVValuation13Valuation: 13th percentileEExpectations49Expectations: 49th percentile |
| 279 | DGXOpen DGX on Seeking Alpha in a new tab.94% of the way from the 52-week low to the 52-week high. | Quest DiagnosticsHealthcare·Medical - Diagnostics & Research | 60 | 53Quality: 53rd percentile | 81Momentum: 81st percentile | 31Growth: 31st percentile | 72Valuation: 72nd percentile | 43Expectations: 43rd percentile | QQuality53Quality: 53rd percentileMMomentum81Momentum: 81st percentileGGrowth31Growth: 31st percentileVValuation72Valuation: 72nd percentileEExpectations43Expectations: 43rd percentile |
| 283 | JNJOpen JNJ on Seeking Alpha in a new tab.85% of the way from the 52-week low to the 52-week high. | Johnson & JohnsonHealthcare·Drug Manufacturers - General | 59 | 46Quality: 46th percentile | 82Momentum: 82nd percentile | 41Growth: 41st percentile | 33Valuation: 33rd percentile | 31Expectations: 31st percentile | QQuality46Quality: 46th percentileMMomentum82Momentum: 82nd percentileGGrowth41Growth: 41st percentileVValuation33Valuation: 33rd percentileEExpectations31Expectations: 31st percentile |
| 286 | DHROpen DHR on Seeking Alpha in a new tab.90% of the way from the 52-week low to the 52-week high. | DanaherHealthcare·Medical - Diagnostics & Research | 59 | 28Quality: 28th percentile | 85Momentum: 85th percentile | 58Growth: 58th percentile | 37Valuation: 37th percentile | 66Expectations: 66th percentile | QQuality28Quality: 28th percentileMMomentum85Momentum: 85th percentileGGrowth58Growth: 58th percentileVValuation37Valuation: 37th percentileEExpectations66Expectations: 66th percentile |
| 290 | EHCOpen EHC on Seeking Alpha in a new tab.84% of the way from the 52-week low to the 52-week high. | Encompass HealthHealthcare·Medical - Care Facilities | 58 | 42Quality: 42nd percentile | 83Momentum: 83rd percentile | 38Growth: 38th percentile | 64Valuation: 64th percentile | 44Expectations: 44th percentile | QQuality42Quality: 42nd percentileMMomentum83Momentum: 83rd percentileGGrowth38Growth: 38th percentileVValuation64Valuation: 64th percentileEExpectations44Expectations: 44th percentile |
| 301 | SYKOpen SYK on Seeking Alpha in a new tab.33% of the way from the 52-week low to the 52-week high. | StrykerHealthcare·Medical - Devices | 57 | 74Quality: 74th percentile | 12Momentum: 12th percentile | 77Growth: 77th percentile | 47Valuation: 47th percentile | 50Expectations: 50th percentile | QQuality74Quality: 74th percentileMMomentum12Momentum: 12th percentileGGrowth77Growth: 77th percentileVValuation47Valuation: 47th percentileEExpectations50Expectations: 50th percentile |
| 305 | BMYOpen BMY on Seeking Alpha in a new tab.77% of the way from the 52-week low to the 52-week high. | Bristol-Myers SquibbHealthcare·Drug Manufacturers - General | 56 | 57Quality: 57th percentile | 68Momentum: 68th percentile | 23Growth: 23rd percentile | 82Valuation: 82nd percentile | 89Expectations: 89th percentile | QQuality57Quality: 57th percentileMMomentum68Momentum: 68th percentileGGrowth23Growth: 23rd percentileVValuation82Valuation: 82nd percentileEExpectations89Expectations: 89th percentile |